Latest Period
n/a
Security Snapshot
Lomond Therapeutics Holdings, Inc. - Common Stock Institutional Ownership
CUSIP: 54173L101
13F Institutional Holders and Ownership History
Institutions Reporting
Shares (Excl. Options)
Price
Save this security research path
Keep this CUSIP in your research flow, then return after the next filing cycle to check what changed.
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 32,208,433
Quick Takeaways
- 54173L101 - Lomond Therapeutics Holdings, Inc. - Common Stock is tracked under CUSIP 54173L101.
- Latest finished 13F holder period is not available.
- 5 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Quarterly ownership records are not available yet for this CUSIP.
- This page updates as SEC-backed holdings history becomes available.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Schedule 13D/13G
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 54173L101?
CUSIP 54173L101 identifies 54173L101 - Lomond Therapeutics Holdings, Inc. - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Significant Owners of Lomond Therapeutics Holdings, Inc. - Common Stock based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Flynn James E | 8.4% | 2,692,625 | Deerfield Mgmt, L.P. | 30 Sep 2025 | ||||
| Yosemite Fund I, L.P. | 8.4% | 2,500,000 | Yosemite Fund I, L.P. | 24 Jan 2025 | ||||
| Qatar Investment Authority | 7.8% | 2,500,000 | Qatar Investment Authority | 24 Mar 2025 | ||||
| Tompkins Mark N. | 4% | 1,187,500 | Mark N. Tompkins | 31 Dec 2024 | ||||
| Jacobs Ian Seth | 0.59% | 175,000 | Ian Jacobs | 31 Dec 2024 |